Status Epilepticus

Seizures caused by swallowing medications or illegal substances among youth have significantly risen over the past 15 years, data presented at the European Emergency Medicine Congress showed.

DENVER – A machine-learning seizure burden monitoring algorithm was able to predict the level of poor functional outcomes in those with neurological conditions, according to new research.

ORLANDO — Although effective treatments have been established for those with epilepsy, there is a need for more and novel therapies, which face barriers of efficacy and access, according to a presenter.

As November is National Epilepsy Awareness Month, Healio has gathered the most recent top stories about the condition that affects 3.4 million Americans each year.

The FDA has granted 510(k) clearance to a medical device company for its software that diagnoses electrographic status epilepticus in adults.

Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status epilepticus in adults.

Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology.

The FDA granted orphan drug designation to PharmaTher for its status epilepticus ketamine treatment, according to a company press release.

Patients with benzodiazepine-refractory convulsive status epilepticus who received a home medication vs. non-home medication did not differ in cessation of clinical seizures with improved consciousness by 60 minutes after drug initiation.

Status epilepticus incurred “a large burden” on patients and the U.S. health care system over a 3-year study of more than 43,000 hospitalizations, with higher mortality risk and hospital costs as disease refractoriness increased.